**Core Concept:** Multiple myeloma is a plasma cell disorder characterized by the proliferation of clonal plasma cells in the bone marrow, leading to disruption of normal hematopoiesis and the production of monoclonal proteins. These monoclonal proteins can cause symptoms and complications, such as hypercalcemia, bone lesions, anemia, and renal impairment.

**Why the Correct Answer is Right:**

Correct Answer: D. Serum protein electrophoresis (SPEP) and urine protein electrophoresis (UPEP)

Serum Protein Electrophoresis (SPEP) and Urine Protein Electrophoresis (UPEP) are diagnostic tests used to detect the presence of monoclonal proteins in the blood and urine, respectively. Multiple myeloma leads to the production of monoclonal proteins, which are electrophoretically distinct from normal immunoglobulins. SPEP and UPEP enable the detection and quantification of these abnormal proteins, confirming the diagnosis of multiple myeloma.

**Why Each Wrong Option is Incorrect:**

A. Bone marrow biopsy (BMB) - While BMB can provide valuable information about the clonal plasma cells and bone marrow involvement, it is not specific for diagnosing multiple myeloma. The presence of monoclonal proteins in the blood and urine is a more sensitive and specific indicator of the disease.

B. Bone marrow aspiration (BMA) - Similar to BMB, BMA also provides information about the clonal plasma cells and bone marrow involvement. However, it is not as specific for diagnosing multiple myeloma as SPEP, UPEP, or a combination of both.

C. Serum calcium level - Hypercalcemia is a common symptom in multiple myeloma, but it is not a diagnostic test. It is related to the presence of monoclonal proteins but cannot confirm the diagnosis by itself.

**Clinical Pearl:** A combination of SPEP, UPEP, and BMB/BMA is the most reliable diagnostic approach for multiple myeloma. However, SPEP and UPEP are crucial tests to detect the presence of monoclonal proteins, which is a hallmark of multiple myeloma and allows for early detection and intervention.